Skip to Content

W43 (Rosiglitazone maleate 8 mg (base))

Pill with imprint W43 is Red, Elliptical / Oval and has been identified as Rosiglitazone maleate 8 mg (base). It is supplied by West-ward Pharmaceutical Corp..

Rosiglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Images for W43

Rosiglitazone maleate

Imprint:
W43
Strength:
8 mg (base)
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
West-ward Pharmaceutical Corp.
National Drug Code (NDC):
00143-9975

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide